Precision medicine is transforming cancer care, but insurance denials are blocking access to biomarker testing for thousands ...

Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

‘I Tried Midi Health for Biomarker Testing—Here’s What I Learned About My Health’ originally appeared on Parade. Considering that I’m a journalist, it’s not a surprise that I believe that knowledge is ...

Mississippi's House Bill 565, known as Jill's Law, aims to provide coverage for biomarker testing to improve cancer treatment ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called tumour or genomic testing, looks for the changes in a tumour’s DNA that drive ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

—A new study of more than 42,000 patients sought to evaluate contemporary trends in testing for biomarkers of non-small cell lung cancer (NSCLC), as well as rates of treatment with ...